Document Details
Form
Filing Date
Feb 2, 2023
Document Date
Jan 31, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
LEE KENNETH B JR